INDEGENE LIMITED

  • Minimum Investment
    ₹14,190
  • Price Range
    ₹430 - ₹452
  • Issue Size
    ₹1,841.76 Cr
  • Lot Size
    33 shares

Proceeds of this IPO to be used for

Repayment/prepayment of indebtedness of one of the material subsidiaries, ILSL Holdings.

Funding the capital expenditure requirements of the company and one of its material subsidiaries.

General corporate purposes and inorganic growth.

Download RHP DocumentGet more in-depth details about this IPO.

Strengths & Weaknesses of INDEGENE LIMITED

Domain expertise

The company's deep understanding of the healthcare domain enables it to efficiently modernize and digitize key functions involved in the life sciences commercialization process

Robust digital capabilities

The company has developed a suite of proprietary tools and platforms that include applications designed to automate processes and create AI-based efficiencies. These applications leverage AI, machine learning (ML), natural language processing (NLP), and advanced analytics capabilities, which are core components of the solutions offered

Long-standing client relationships

The company has long-standing relationships with marquee biopharmaceutical companies, including each of the 20 largest biopharmaceutical companies in the world by revenue for FY23

Global delivery model

The company caters to the needs of its clients from six operation hubs and 17 offices located across North America, Europe, and Asia

Dependent on subsidiaries

The majority of the company's revenues are derived from its subsidiaries. Therefore, any disruptions in the operations of one or more of its subsidiaries could adversely affect the business, financial condition, and results of operations

Sales efforts

The company's sales efforts involve considerable time and expense, and there is a risk that the revenues generated may not justify the expenses incurred towards these sales efforts

Outstanding legal proceedings

There are outstanding legal proceedings involving the company, its subsidiaries, and directors. Any adverse decision in these proceedings could adversely affect the business and results of operations

Contingent liabilities

The company has certain contingent liabilities and commitments that, if realized, may adversely affect its financial condition

Financials

Earnings Per Share

Earnings Per Share (EPS) is calculated by dividing a company’s net income by its average number of outstanding shares.

No Data

Balance Sheet

A financial statement that provides details about a company’s assets, liabilities, and shareholders’ equity at a given point in time.
Particulars (In Cr)Y/Y Change
Total Current Assets--
Total Non-Current Assets--
Fixed assets--
Total assets--
Total Current Liabilities--
Total Non-Current Liabilities--
Total Capital Plus Liabilities--
Total Shareholder Funds--
Total Debt to Equity--

Cash Flow

The net amount of cash or cash equivalents being transferred in and out of a company for a specified period of time. Cashflow stems from operating, investing and financing activities.
Particulars (In Cr)Y/Y Change
Cash from Operating Activity--
Cash from Financing Activities--
Cash from Investing Activities--
Net Cash Flow--

About INDEGENE LIMITED

Indegene was incorporated on October 16, 1998. The company offers digital-led commercialization services for the life sciences industry, serving biopharmaceutical companies, emerging biotech, and medical devices companies. It assists these entities with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.

    INDEGENE LIMITED IPO FAQs

    What is INDEGENE LIMITED IPO?

    INDEGENE LIMITED IPO refers to the initial public offering of shares by INDEGENE LIMITED. It is a process by which the company offers its shares to the public for the first time, allowing individuals to become shareholders.

    What is the issue size of INDEGENE LIMITED IPO?

    For INDEGENE LIMITED IPO the issue size is ₹1,842 Cr. The issue size is the total value of the shares offered to the public. It represents the amount the company aims to raise through the IPO.

    What is the minimum investment amount for the INDEGENE LIMITED IPO?

    For INDEGENE LIMITED IPO the minimum investment is ₹14,190. The minimum investment for INDEGENE LIMITED IPO is the smallest amount an individual can invest to participate in the offering. It is usually determined by the company and regulatory requirements.

    What is the lot size of INDEGENE LIMITED IPO?

    For INDEGENE LIMITED IPO the lot size is 33 shares. The lot size of INDEGENE LIMITED IPO refers to the number of shares that investors need to bid for and purchase in a single transaction. It is predetermined by the company and regulators.

    How to apply for INDEGENE LIMITED IPO on Share.Market?

    To apply for INDEGENE LIMITED IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the INDEGENE LIMITED IPO from the list and click on apply now. Place your bids or choose the Cut-off Price option. Enter your UPI ID and set up your mandate to place your application.

    Can I pre-apply for INDEGENE LIMITED IPO?

    Yes, investors can often pre-apply for some of the IPOs. Pre-application allows individuals to express their interest in participating in the IPO before the official subscription period begins. To pre- apply for INDEGENE LIMITED IPO on Share.Market, go to the home page section and click/press on the browse IPOs section to view the open and upcoming IPOs. Select the IPO from the list and click on pre-apply now. Once the IPO opens for subscription you can enter your UPI ID and set up your mandate to place your application.

    How many days is the IPO application window open?

    The IPO application window typically remains open for 3 days, starting from the date of the IPO opening. However, this duration can vary depending on the specific IPO and the regulatory requirements.

    Till what time can I apply for an IPO on the last day on Share.Market?

    You can apply for the IPO till 3 PM on the last day of application on Share.Market.

    What is the allotment date of INDEGENE LIMITED IPO?

    For INDEGENE LIMITED IPO the allotment date is May 9, 2024. The allotment date of INDEGENE LIMITED IPO is the date on which shares are allocated to the successful bidders. It marks the distribution of shares to investors.

    What are the open and close dates of INDEGENE LIMITED IPO?

    For INDEGENE LIMITED IPO, the subscription opens on May 6, 2024 and closes on May 8, 2024. The open and close dates of an IPO indicate the period during which investors can submit their bids to participate in the offering.
    Bidding Ongoing
    -
    Total Subscription
    69.62x Oversubscribed